BioSyent Pharma Inc. is focused on providing a distinguishable benefit to Canadian patients and their healthcare providers through innovation. With our deep expertise and experience in promoting women’s health, we strive to deliver products that are unique and provide meaningful therapeutic advantages over existing therapies. Our portfolio of healthcare products includes a patented oral hematinic (FeraMAX® Pd), a unique prescription hormone replacement therapy for menopause (Tibella®), an innovative suppository for vaginal dryness (RepaGyn®), and the first ever Acetaminophen + Ibuprofen combination available in Canada (Combogesic®).
Company Details
- Employees
- 2
- Address
- 2476 Argentia Rd, Suite 402,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Mississauga, Ontario
Biosyent Brands Questions
Biosyent Brands's website is http://www.biosyent.com/rx/home/#.YPWHXuhKjIU
Biosyent Brands's LinkedIn profile is https://ca.linkedin.com/company/biosyent-brands
Biosyent Brands has
2 employees.
View email and phone details for 2
employees at Biosyent Brands.
Biosyent Brands's industry is
Pharmaceutical Manufacturing
Biosyent Brands's top competitors are
Mint Pharmaceuticals,
Omniabio,
Syneos Health,
Ccrm,
Cipher Pharmaceuticals Inc. (Tsx: Cph) (Otcqx:cphrf),
Fusion Pharmaceuticals,
Jazz Pharmaceuticals,
Apotex Inc.,
Seaford Pharmaceuticals Inc.,
Tribe Medical, Arthrex Agency Partner.
Biosyent Brands's categories are Pharmaceutical Manufacturing
